Breakthrough T1D Clinical & Research Congress

The inaugural Breakthrough T1D Clinical & Research Congress is a significant event dedicated to improving the lives of individuals affected by autoimmune type 1 diabetes (T1D) and advancing the quest for a cure. This congress will take place in Philadelphia, a city renowned for its medical innovation and the birthplace of Breakthrough T1D over fifty years ago. The event aims to foster multidisciplinary collaboration across the T1D ecosystem, bringing together an array of participants including clinicians, researchers, basic scientists, allied health professionals, advocates, policymakers, industry leaders, and individuals living with T1D. The congress will provide a platform for sharing insights, generating ideas, and spurring innovation across the continuum of care and potential cures for T1D.Attendees can look forward to an engaging agenda that includes accredited interactive sessions, plenary lectures, workshops, and networking opportunities over two and a half days. The event will feature discussions on the latest advancements in T1D discovery science, immunotherapies, automated insulin delivery systems, islet cell therapies, psychosocial care models, health equity strategies, and real-world data. With a focus on translational updates and rigorous dialogue, the congress seeks to unite the T1D community in an effort to shape the future of care and ultimately achieve a world without T1D. Esteemed speakers at the congress include Thomas Danne, Sanjoy Dutta, and Anastasia Albanese-O'Neill, who will contribute their expertise and insights to this pivotal forum.